Ildong Pharmaceutical Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Ildong Pharmaceutical Stock Forecast and Price Target
According to experts, who recently provided their 2024 price targets for Ildong Pharmaceutical, the average price target is ₩25000.00, with a high estimate of ₩25000.00 and a low estimate of ₩25000.00. That is a potential upside of approximately 60.98% from the last closing price of ₩15530.00 on May, 2024. If interested in A249420 stock, you may also want to consider its competitors.
60.98% Upside
Ildong Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Ildong Pharmaceutical's Price has grown, increasing from ₩0.00 to ₩0.00 – a growth of 100.00%. The next year looks promising for Ildong Pharmaceutical, with analysts predicting Fair Value of ₩0.00 – an increase of 100.00%. Over the next six years, experts anticipate that Ildong Pharmaceutical's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A128940 Stock Forecast | Hanmi Pharm. | Outperform |
18
|
₩316.50k | Buy/Sell | ₩382.71k | 31.12% |
| A008930 Stock Forecast | Hanmi Science | - |
14
|
₩42.55k | Buy/Sell | ₩0.00 | -100.00% |
| A000250 Stock Forecast | Sam Chun Dang Pharm. | - |
6
|
₩104.60k | Buy/Sell | ₩80.00k | -100.00% |
| A145020 Stock Forecast | Hugel | Buy |
16
|
₩211.50k | Buy/Sell | ₩201.75k | 3.55% |
| A009420 Stock Forecast | Hanall Biopharma | Buy |
14
|
₩36.10k | Buy/Sell | ₩44.67k | 24.65% |
Ildong Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Ildong Pharmaceutical's Revenue has grown, increasing from ₩561.85B to ₩637.71B – a growth of 13.50%. For the next year, 0 analysts project Ildong Pharmaceutical's Revenue to drop by 8.01%, reaching ₩586.63B. By 2030, professionals believe that Ildong Pharmaceutical's Revenue will decrease by 7.72%, reaching ₩588.49B – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A019170 Stock Forecast | Shinpoong Pharmaceutical Co.,L... | - |
14
|
₩12.96k | Buy/Sell | ₩0.00 | -100.00% |
| A185750 Stock Forecast | Chong Kun Dang Pharmaceutical | Outperform |
16
|
₩104.30k | Buy/Sell | ₩124.29k | 43.82% |
| A069620 Stock Forecast | Daewoong pharmaceutical Co.,Lt... | Buy |
16
|
₩111.90k | Buy/Sell | ₩156.10k | 42.98% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A005250 Stock Forecast | Green Cross Holdings | - |
16
|
₩16.17k | Buy/Sell | ₩0.00 | -100.00% |
| A003090 Stock Forecast | Daewoong | Outperform |
14
|
₩18.82k | Buy/Sell | ₩38.00k | 32.84% |
| A003850 Stock Forecast | Boryung | Buy |
17
|
₩11.15k | Buy/Sell | ₩13.50k | 43.50% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A086450 Stock Forecast | DongKook Pharmaceutical | Buy |
16
|
₩16.48k | Buy/Sell | ₩20.00k | 45.63% |
| A001060 Stock Forecast | JW Pharmaceutical | Buy |
14
|
₩30.95k | Buy/Sell | ₩40.62k | 35.70% |
| A000640 Stock Forecast | Dong-A Socio Holdings | - |
13
|
₩110.20k | Buy/Sell | ₩0.00 | -100.00% |
Ildong Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Ildong Pharmaceutical's EBITDA has seen a drop from ₩33.19B to ₩-44.12B – a 232.93% decrease. For next year, analysts predict EBITDA of ₩-65.59B, which would mean an increase of 48.67%. Over the next eight years, experts predict that Ildong Pharmaceutical's EBITDA will grow at a rate of 57.13%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A170900 Stock Forecast | Dong-A ST | Outperform |
17
|
₩67.60k | Buy/Sell | ₩74.50k | 20.56% |
| A058820 Stock Forecast | CMG Pharmaceutical | - |
14
|
₩2.24k | Buy/Sell | ₩0.00 | -100.00% |
| A140410 Stock Forecast | Mezzion Pharma | - |
6
|
₩36.55k | Buy/Sell | ₩0.00 | -100.00% |
Ildong Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Ildong Pharmaceutical's EBIT has gone down from ₩5.53B to ₩-73.67B – a 1432.33% drop. For next year, analysts predict EBIT of ₩-87.88B, which would mean an increase of 19.29%. Over the next eight years, experts predict that Ildong Pharmaceutical's EBIT will grow at a rate of 19.98%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A102460 Stock Forecast | REYON Pharmaceutical | - |
15
|
₩15.75k | Buy/Sell | ₩0.00 | -100.00% |
| A047920 Stock Forecast | HLB Pharmaceutical | - |
4
|
₩34.10k | Buy/Sell | ₩0.00 | -100.00% |
| A003000 Stock Forecast | Bukwang Pharmaceutical | - |
10
|
₩6.36k | Buy/Sell | ₩17.66k | -100.00% |
Ildong Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Ildong Pharmaceutical's EPS has grown, increasing from ₩-5363.00 to ₩0.00 – a growth of 100.00%. The next year looks promising for Ildong Pharmaceutical, with analysts predicting EPS of ₩0.00 – an increase of 100.00%. Over the next six years, experts anticipate that Ildong Pharmaceutical's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A053030 Stock Forecast | BINEX | - |
16
|
₩14.01k | Buy/Sell | ₩18.00k | -100.00% |
| A007570 Stock Forecast | Ilyang Pharmaceutical Co.,Ltd | - |
13
|
₩14.56k | Buy/Sell | ₩0.00 | -100.00% |
| A243070 Stock Forecast | Huons | Outperform |
18
|
₩34.50k | Buy/Sell | ₩45.00k | 56.52% |
Site Navigation
.jpg)